Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “GENERAL REGENERATIVES, LTD.”

5 pharma patents match "GENERAL REGENERATIVES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "GENERAL REGENERATIVES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “GENERAL REGENERATIVES, LTD.” · 30,257 patents in full index Clear search

  1. US 9339528

    Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist

    GENERAL REGENERATIVES, LTD. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  2. US 9283300

    Use of midkine protein and the protein-containing medical device

    GENERAL REGENERATIVES, LTD. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  3. US 8367052

    Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

    GENERAL REGENERATIVES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  4. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    GENERAL REGENERATIVES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  5. US 7943131

    Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

    GENERAL REGENERATIVES, LTD. · Granted May 17, 2011 · Expires May 12, 2031

    granted